Freestone Capital Holdings, LLC Biocryst Pharmaceuticals Inc Transaction History

Freestone Capital Holdings, LLC

  • $2.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$11.56 - $19.76 $231,200 - $395,200
-20,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$11.18 - $15.46 $223,600 - $309,200
20,000 New
20,000 $277,000
Q1 2021

May 17, 2021
SELL
$7.37 - $13.61 $14,740 - $27,220
-2,000 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$3.43 - $5.53 $6,860 - $11,060
2,000 New
2,000 $6,000

Others Institutions Holding BCRX

# of Institutions
278
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.45B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email